Journal ArticleOPEN ACCESS

CNS Metastases in Patients With MET Exon 14–Altered Lung Cancers and Outcomes With Crizotinib

  • Offin M
  • Luo J
  • Guo R
  • et al.
JCO Precision Oncology (2020) (4) 871-876
DOI: 10.1200/po.20.00098
28Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

PURPOSEAlthough MET exon 14 (METex14)–altered lung cancers were first identified more than a decade and a half ago, the frequency of CNS metastatic disease remains poorly defined. Furthermore, the ...

Cite

CITATION STYLE

APA

Offin, M., Luo, J., Guo, R., Lyo, J. K., Falcon, C., Dienstag, J., … Drilon, A. (2020). CNS Metastases in Patients With MET Exon 14–Altered Lung Cancers and Outcomes With Crizotinib. JCO Precision Oncology, (4), 871–876. https://doi.org/10.1200/po.20.00098

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free